Brensocatib Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 10mg, 25mg
Reference Brands: Brinsupri (USA/EU)
Category:
Respiratory Disorder
Brensocatib (brand name Brinsupri) is an orally-administered, once-daily small-molecule inhibitor of dipeptidyl peptidase 1 (DPP1), which in turn reduces activation of neutrophil serine proteases responsible for airway inflammation and tissue damage in chronic lung disease. It is indicated for treatment of non-cystic fibrosis bronchiectasis (NCFB) in patients aged 12 years and older, representing the first therapy specifically approved for this condition. In clinical trials, brensocatib reduced the annual rate of disease exacerbations and slowed lung function decline. Being the first in its class, it offers a novel mechanism targeting neutrophil-driven inflammation rather than purely the infection component.
Brensocatib is available in Tablets
and strengths such as 10mg, 25mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Brensocatib is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Brensocatib can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing